Amgen says cloud data breach exposed patient health, proprietary info

Pharmaceutical company Amgen disclosed a data breach in July 2026 involving unauthorized access to sensitive data stored in third-party cloud environments. The stolen data includes patient protected health information, proprietary data, and potentially intellectual property and research information. The breach was detected internally, and Amgen is investigating with forensic experts, though technical details such as the attack vector, affected providers, or attribution remain undisclosed. The incident is under evaluation for regulatory reporting obligations.

AI-extracted · verify before operational use